These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26705474)

  • 21. Managing the perioperative patient on direct oral anticoagulants.
    Leitch J; van Vlymen J
    Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures.
    Deutsch D; Boustière C; Ferrari E; Albaladejo P; Morange PE; Benamouzig R
    Therap Adv Gastroenterol; 2017 Jun; 10(6):495-505. PubMed ID: 28567119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What we have learned about direct oral anticoagulant reversal.
    Siegal DM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):198-203. PubMed ID: 31808835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications.
    Shieh WS; Sridhar J; Hong BK; Maguire JI; Rahimy E; Shahlaee A; Ho AC; Hsu J; Regillo CD; Chiang A
    Semin Ophthalmol; 2017; 32(5):614-619. PubMed ID: 27367495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency admissions for major haemorrhage associated with direct oral anticoagulants.
    Bouget J; Oger E
    Thromb Res; 2015 Dec; 136(6):1190-4. PubMed ID: 26545315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of bleeding associated with direct oral anticoagulants: update on reversal strategies].
    Enríquez A; Baranchuk A; Corbalán R
    Rev Med Chil; 2019; 147(1):73-82. PubMed ID: 30848768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients.
    Umei M; Kishi M; Sato T; Shindo A; Toyoda M; Yokoyama M; Matsushita M; Ohnishi S; Yamasaki M
    J Arrhythm; 2017 Oct; 33(5):475-482. PubMed ID: 29021853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature.
    Shaw JR; Castellucci LA; Siegal D; Carrier M
    J Thromb Haemost; 2023 Mar; 21(3):433-452. PubMed ID: 36696204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Target-Specific Oral Anticoagulants and Intracranial Bleeding: Management and Outcome in a Single-Center Case Series.
    Senger S; Keiner D; Hendrix P; Oertel J
    World Neurosurg; 2016 Apr; 88():132-139. PubMed ID: 26732970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort.
    Butt JH; Li A; Xian Y; Peterson ED; Garcia D; Torp-Pedersen C; Køber L; Fosbøl EL
    Am Heart J; 2019 Oct; 216():117-124. PubMed ID: 31425898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
    Eikelboom J; Merli G
    Am J Med; 2016 Nov; 129(11S):S33-S40. PubMed ID: 27586367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
    Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E
    Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
    Desai NR; Cornutt D
    Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major bleeding complications in patients treated with direct oral anticoagulants: One-year observational study in a Paris Hospital.
    Deville L; Konan M; Hij A; Goldwirt L; Peyrony O; Fieux F; Faure P; Madelaine I; Villiers S; Farge-Bancel D; Frère C
    Curr Res Transl Med; 2016; 64(3):129-133. PubMed ID: 27765272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding with direct oral anticoagulants vs warfarin: clinical experience.
    Eikelboom J; Merli G
    Am J Emerg Med; 2016 Nov; 34(11S):3-8. PubMed ID: 27697439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of bleeding complications in patients with cancer on DOACs.
    Schulman S; Shrum J; Majeed A
    Thromb Res; 2016 Apr; 140 Suppl 1():S142-7. PubMed ID: 27067968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.